Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP844180.RAokyiTf5SRLh6TuxKxk4HeLaQWmUWef2B8ZtK3BVR7JA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP844180.RAokyiTf5SRLh6TuxKxk4HeLaQWmUWef2B8ZtK3BVR7JA130_assertion type Assertion NP844180.RAokyiTf5SRLh6TuxKxk4HeLaQWmUWef2B8ZtK3BVR7JA130_head.
- NP844180.RAokyiTf5SRLh6TuxKxk4HeLaQWmUWef2B8ZtK3BVR7JA130_assertion wasGeneratedBy ECO_0000203 NP844180.RAokyiTf5SRLh6TuxKxk4HeLaQWmUWef2B8ZtK3BVR7JA130_provenance.
- NP844180.RAokyiTf5SRLh6TuxKxk4HeLaQWmUWef2B8ZtK3BVR7JA130_assertion wasDerivedFrom befree-20140225 NP844180.RAokyiTf5SRLh6TuxKxk4HeLaQWmUWef2B8ZtK3BVR7JA130_provenance.
- NP844180.RAokyiTf5SRLh6TuxKxk4HeLaQWmUWef2B8ZtK3BVR7JA130_assertion SIO_000772 8690051 NP844180.RAokyiTf5SRLh6TuxKxk4HeLaQWmUWef2B8ZtK3BVR7JA130_provenance.
- NP844180.RAokyiTf5SRLh6TuxKxk4HeLaQWmUWef2B8ZtK3BVR7JA130_assertion evidence source_evidence_literature NP844180.RAokyiTf5SRLh6TuxKxk4HeLaQWmUWef2B8ZtK3BVR7JA130_provenance.
- NP844180.RAokyiTf5SRLh6TuxKxk4HeLaQWmUWef2B8ZtK3BVR7JA130_assertion description "[Our results indicate that treatment with anti-CD52 or anti-CD45 mAbs potentially may be useful as adjuvant immunotherapy for systemically disseminated B cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP844180.RAokyiTf5SRLh6TuxKxk4HeLaQWmUWef2B8ZtK3BVR7JA130_provenance.